However, it demonstrated that IL-17 concentration showed a positive correlation with the level of IL-6 (r = 0.5415, P = 0.0009) (Figure 5(a)) in ND AML patients, but did not reach statistical correlation in CR, relapsed-refractory, or control groups. Here, IL6 is linked to acute myeloid leukemia.